Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis

I J Chan1, S Kasprowicz, M D Tharp

  • 1Department of Dermatology, Rush University Medical Center, Chicago, IL, USA. ichan@rush.edu

Abstract

Insights

Activating KIT mutations in mastocytosis utilize distinct signaling pathways. KIT(V560G) activates JAK3/STAT, while KIT(D816V) activates mTORC1. Inhibiting these pathways induces cell death, offering new mastocytosis treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Activating mutations in the KIT gene, specifically KIT(V560G) and KIT(D816V), are strongly associated with mastocytosis.
  • Targeting signaling pathways downstream of mutated KIT presents a promising therapeutic strategy for mastocytosis.

Purpose of the Study:

  • To investigate and correlate specific KIT mutations with their associated signaling pathways in human mast cell lines.
  • To utilize pathway inhibitors to elucidate the functional roles of these pathways in mastocytosis.

Main Methods:

  • Human mast cell lines (HMC-1 and HMC-1.2) expressing KIT(V560G) and dual KIT(V560G)/KIT(D816V) mutations were treated with specific pathway inhibitors.
  • Cell proliferation was assessed using MTT assays, and protein expression/pathway activation was analyzed via western blotting and flow cytometry.

Main Results:

  • The Janus kinase 3/signal transducer and activator of transcription (JAK3/STAT) pathway was identified as the primary pathway for KIT(V560G).
  • The mechanistic target of rapamycin complex 1/4E-binding protein 1 (mTORC1/4E-BP1) pathway was found to be preferentially linked to KIT(D816V).
  • Inhibition of these identified pathways led to programmed cell death in mast cells.

Conclusions:

  • KIT(V560G) and KIT(D816V) mutations activate distinct signaling cascades that drive mast cell proliferation.
  • Targeted inhibition of the JAK3/STAT pathway for KIT(V560G) and the mTORC1/4E-BP1 pathway for KIT(D816V) shows potential for treating mastocytosis.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...